Ghost RX Inc.

Ghost RX Inc., a Service-Disabled Veteran-Owned Small Business headquartered in Orlando, Florida, supplies temporary clinical healthcare staffing across nursing, medical technology, laboratory services, pharmacy, and specialized physician roles to the Department of Veterans Affairs, Indian Health Service, and federal correctional facilities as a prime contractor on the GSA Professional and Allied Healthcare Staffing Services schedule (FSS-621-I) and through associated single and multiple-award blanket purchase agreements and indefinite delivery contracts. The company is a Subchapter S Corporation structured as a for-profit veteran-owned and service-disabled veteran-owned entity competing predominantly under SDVOSB and full-and-open set-asides across its federal footprint.

Ghost RX's customer concentration is heavily weighted to the VA regional networks. The top five customers by potential value account for 70% of combined potential dollars—Department of Veterans Affairs Veterans Integrated Service Network 10 (37 awards, $161.6 million), VISN 22 ($140.9 million across 30 awards), VISN 20 (37 awards, $87.5 million), VISN 2 (40 awards, $71.7 million), and VISN 12 (26 awards, $70.4 million)—with the Indian Health Service adding a second tier ($26.2 million across 153 awards). The award-count and dollar-value rankings track closely: VISN 10 dominates both volume and dollars, while IHS ranks first by count but fifth by value, reflecting smaller task-order sizes. Ghost RX works across 25 distinct federal agencies overall; beyond the VA and IHS, the Bureau of Prisons, Bureau of Justice Assistance, and NIH Clinical Center have issued task orders.

The vendor's primary vehicle is the $44.6 million GSA Professional and Allied Healthcare Staffing Services Federal Supply Schedule (FSS-621-I), from which 313 task orders worth $508.2 million have been placed—accounting for 67% of Ghost RX's combined potential value. Beyond the FSS-621-I, Ghost RX holds multiple single-award and multiple-award BPAs and indefinite delivery contracts anchored to that schedule. Representative single-award vehicles include a $37.7 million BPA with VISN 22 for Southern Arizona VA Health Care System nurse staffing (awarded December 2023, performance through December 2028), a $31.2 million BPA with VISN 22 for New Mexico VA Health Care System nursing services (December 2023 through November 2028), a $26.5 million indefinite delivery contract with VISN 22 for VA San Diego Healthcare System nurse staffing (September 2023 through September 2025), and a $22.1 million BPA with VISN 19 for nursing services at Eastern Colorado Health Care System (October 2024 through September 2029). Additional single-award vehicles include a $19.8 million BPA with VISN 22 for Phoenix VA Health Care System nursing (March 2024 through February 2029) and an $8.6 million BPA with VISN 4 for medical technologists in Wilmington and Philadelphia (March 2023 through August 2028). These BPAs and IDCs are predominantly set-aside for SDVOSB and enable firm fixed-price task ordering across on-demand clinical staffing needs.

Activity trended down in recent years: Ghost RX received 64 awards in 2022, declining to 62 in 2023, 54 in 2024, 27 in 2025, and 20 year-to-date in 2026 (as of October 1, 2026). The recompete cliff window (next 24 months from the October 2026 analysis date) includes 26 awards with combined potential value of $32.8 million reaching ultimate completion. No awards are currently pending recompete that would force a material loss of revenue, though the multi-million-dollar nursing and technologist vehicles with VISN 10, VISN 22, and VISN 20 will require renewal attention in 2027 and 2028.

SCI-reported invoicing across federal service contracts above the $150,000 threshold shows $88.7 million cumulative across FY2023–FY2025: $41.6 million in FY2023 (180 FTEs), $26.5 million in FY2024 (135 FTEs), and $20.6 million in FY2025 (135 FTEs). SCI data covers only prime service contracts and excludes goods, micro-purchases, and non-federal work; these figures represent a strict subset of Ghost RX's total federal revenue. Across SCI-reportable prime contracts, Ghost RX self-performs its labor with no subcontractor engagement (0% average sub-hours share), pricing government-paid rates at a median of $89.04 per hour, with the 10th percentile around $41.31 per hour and the 90th percentile reaching $200.90 per hour—reflecting variation across clinical specialties and geographic wage determinations. The company held 211 SCI prime records and 2 named subcontractor records in the source data (both under Optumhealth Care Solutions, LLC for global nurse advice line staffing as of September 2025).

Ghost RX's award portfolio spans primarily nursing (98 awards under Medical-Nursing PSC), pharmacy (128 awards under Pharmacy Services PSC), medical technology and managed healthcare (77 awards under Medical-Managed Healthcare, 64 under Medical-Other), and temporary staffing more broadly (324 awards under NAICS 561320 for temporary help services). The vendor competes across full-and-open and set-aside categories but anchors most of its portfolio to SDVOSB set-asides on its GSA Schedule and associated BPAs, reflecting its core market positioning as a preferred service-disabled veteran-owned provider to the VA system.

Contract pharmacist service